Tagged with Healthcare

Denmark Steve Wright, General Manager of Boehringer Ingelheim Denmark and Norway, shares insights on how the company is advancing its ambitious pipeline and aligning with Denmark’s national healthcare priorities. In this interview, Wright discusses Boehringer Ingelheim’s strategic focus on innovation, access, and prevention, while reflecting on the company’s evolving role in…

Denmark Jakob Nielsen, CEO of Healthcare Denmark, discusses how Denmark has strengthened its role in global health diplomacy and life sciences since 2021. Nielsen highlights the country’s focus on strategic international partnerships, digitalisation, and patient-centric healthcare reform, positioning Denmark as a transparent and collaborative partner in addressing shared healthcare challenges. What…

Saudi Arabia When it was first initiated back in 2016, in the wake of the launch of Vision 2030, few industry insiders could have anticipated just quite how radical Saudi Arabia’s Health Sector Transformation Program (HSTP) would turn out to be. Since then, several significant milestones have been reached – the retreat…

Mexico Mexico has a long history of public healthcare reforms that have fluctuated along with the changing tides of the country’s government. The latest is an ambitious plan for the Institute of Social Security and Services for State Workers (ISSSTE). Aimed at expanding the reach of public services, the scheme announced…

Saudi Arabia As Saudi Arabia continues its ambitious healthcare transformation under Vision 2030, the Ministry of Health is playing a central role in reimagining the nation’s approach to health and wellness. Fahad bin Abdulrahman AlJalajel, His Excellency, the Minister of Health, outlines key milestones in the shift toward a value-based healthcare system,…

APAC This week’s Asia healthcare and pharma roundup from PharmaBoardroom content partner Selesta covers China’s USD 36.2bn in outbound licensing agreements, Henlius & EssexBio meeting Phase III endpoints, Organon acquiring US rights of tocilizumab biosimilar from Biogen, GE Healthcare’s acquisition of Japan’s Nihon Medi-Physics, Wuxi Biologics’ disposal of vaccine facility to…

APAC This week’s Asia healthcare and pharma roundup from PharmaBoardroom content partner Selesta covers the AACR 2025 ADC pipeline list from China, Puhe out-licensing global rights of a PRMT5 inhibitor to Bayer, AbbVie accusing Genmab of ADC trade secret theft on ADC technology used by ProfoundBio, and Singapore’s A*STAR investing in…

Saudi Arabia With a presence in the region spanning over six decades, Boehringer Ingelheim is entering a new chapter – one defined by deeper partnerships, accelerated innovation, and a broader role in shaping healthcare systems. At the center of this evolution is Abdallah Hamed, leading operations across Saudi Arabia, Gulf, and East…

Saudi Arabia Dr Nasreen Alfaris, a leading Endocrinology, Diabetes, and obesity physician consultant in Saudi Arabia, shares insights into the evolving landscape of obesity medicine in the Kingdom. She discusses her role in establishing the Saudi Obesity Medicine Fellowship Program, the significant strides made in obesity awareness and treatment, and Saudi Arabia’s…

Saudi Arabia Saudi Arabia is rapidly transforming into a key battleground for the consumer healthcare industry, and Haleon is positioning itself at the forefront of this shift. With a growing appetite for innovation, a highly engaged consumer base, and a regulatory landscape that demands agility, the company is reshaping its strategy to…

Saudi Arabia Majid Al Fayyadh, CEO of King Faisal Specialist Hospital and Research Centre (KFSHRC), discusses the hospital’s transformation into a world-class medical and research institution, aligning with Saudi Arabia’s Vision 2030. He shares insights into KFSHRC’s pioneering efforts in oncology, transplantation, genetics, and cutting-edge medical technology, as well as its role…

Saudi Arabia Michio Kondo, Fujifilm’s MEA managing director, discusses the company’s remarkable growth in the Middle East and Africa since 2022, highlighting key developments such as the acquisition of Hitachi’s imaging division in 2021, which expanded their product portfolio to include MRI, CT, and ultrasound equipment. Fujifilm has also strengthened its presence…